A Dose Escalation Study of Bradanicline in Refractory Chronic Cough

NCT03622216 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Cough

Interventions

DRUG: Bradanicline
DRUG: Placebo

Sponsor

Attenua, Inc.